Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia

Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Wednesday the launch of Redecan EU-GMP certified medical cannabis products in Australia.

What Happened: The following Redecan products are now available for medical cannabis patients in Australia, including:

Redecan PC THC28 Purple Churro – 15g
Redecan SA THC28 Space Age Cake – 15g

Why It Matters: Denise Faltischek, chief strategy officer and head of international at Tilray Brands, praised the move.

Read Also: Tilray’s CBD100 Approved For Clinical Trials In Australia And New Zealand By The Natural Health Science Foundation

Get Benzinga’s exclusive analysis and …

Full story available on Benzinga.com